We are live on ! Find out more
EAM

Exane Asset Management Portfolio holdings

AUM $277M
1-Year Est. Return 26.27%
This Fund
S&P 500
This Quarter Est. Return
-1.01%
1 Year Est. Return
+26.27%
3 Year Est. Return
+77.5%
5 Year Est. Return
+80.92%
10 Year Est. Return
+419.8%
AUM
$333M
AUM Growth
+$11.3M
Cap. Flow
+$20M
Cap. Flow %
6.01%
Top 10 Hldgs %
59.33%
Holding
178
New
81
Increased
27
Reduced
13
Closed
55

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$13.5M
2
PPG icon
PPG Industries
PPG
+$12.7M
3
UBS icon
UBS Group
UBS
+$11.1M
4
AXTA icon
Axalta
AXTA
+$10.5M
5
GRA
W.R. Grace & Co.
GRA
+$9.65M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$19.8M
2
TIMB icon
TIM SA
TIMB
+$16.8M
3
BIIB icon
Biogen
BIIB
+$11.8M
4
APD icon
Air Products & Chemicals
APD
+$9.94M
5
FTI icon
TechnipFMC
FTI
+$9.82M

Sector Composition

Rank Sector Weight
1 Healthcare 32.16%
2 Materials 29.34%
3 Financials 10.86%
4 Technology 8.83%
5 Communication Services 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RGC
176
DELISTED
Regal Entertainment Group
RGC
– –
-39,060
Closed -$899K
BV
177
DELISTED
Bazaarvoice, Inc.
BV
– –
-35,200
Closed -$192K
BOBE
178
DELISTED
Bob Evans Farms, Inc.
BOBE
– –
-10,000
Closed -$788K
4 5 6 7
8

Similar funds

RCA
Ranch Capital Advisors Sarasota, Florida $277M AUM 22.08% 1-Year Est. Return
IIA
ICW Investment Advisors Scottsdale, Arizona $277M AUM 12.1% 1-Year Est. Return
TAP
Tounjian Advisory Partners Fort Myers, Florida $277M AUM 21.37% 1-Year Est. Return
TLA
Tanglewood Legacy Advisors Houston, Texas $276M AUM 16.97% 1-Year Est. Return
1NWS
1 North Wealth Services Annapolis, Maryland $277M AUM 15.28% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return
AA
Alta Advisers London, United Kingdom $276M AUM 26.84% 1-Year Est. Return

Exane Asset Management's Q1 2018 Portfolio in Review

As of Q1 2018, Exane Asset Management held 178 positions worth $333M, up 3.5% from $322M the previous quarter. Its ten largest holdings account for 59% of the portfolio.

Exane Asset Management deployed $20M of net new capital in Q1 2018, opening 81 new positions and adding to 27 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 112,999 shares worth $12.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 39% a quarter earlier, followed by Materials and Financials.

On the sell side, the largest reduction was Gilead Sciences, an estimated $19.8M trimmed.

  • Exane Asset Management's largest Q1 2018 buy was Alexion Pharmaceuticals: 112,999 shares worth $12.6M.
  • Exane Asset Management added most to UBS Group in Q1 2018, an estimated $11.1M increase.
  • Exane Asset Management's biggest Q1 2018 reduction was Gilead Sciences, cutting an estimated $19.8M.
  • Exane Asset Management fully exited TIM SA in Q1 2018, selling an estimated $16.8M.
  • Exane Asset Management's ten largest holdings make up 59% of its $333M portfolio in Q1 2018.
  • Exane Asset Management opened 81 new positions and closed 55 in Q1 2018.
  • Exane Asset Management's portfolio value rose 3.5% quarter-over-quarter to $333M.

Based on Exane Asset Management's 13F filing for Q1 2018, filed 30 Apr 2018.